A Plus Biotechnology Co Ltd · TWSE:6918

A Plus Biotechnology Co Ltd financial statements

A Plus Biotechnology Co Ltd's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue835.9M769.6M675.0M615.5M541.9M
Cost of revenue262.4M234.8M214.4M243.9M195.5M
Gross profit573.5M534.8M460.7M371.5M346.4M
Research and development46.6M53.3M59.5M77.0M63.1M
Selling, general and administrative318.1M299.2M233.4M227.9M237.2M
Operating income208.8M182.3M167.7M66.6M46.1M
Depreciation and amortization27.2M26.7M26.4M24.9M21.4M
EBITDA236.0M209.0M194.1M91.5M67.6M
Interest expense2.17M2.19M2.71M2.66M2.20M
Income before tax216.1M187.6M3.04M68.1M46.1M
Net income169.4M151.1M-11.3M45.7M32.9M
Earnings per share, basic4.964.96-0.371.501.08

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents604.4M361.0M319.1M237.7M305.1M
Short-term investments5.00M31.0M1.00M1.00M1.00M
Receivables177.6M179.0M141.7M145.1M128.9M
Inventory354.5M286.9M283.8M295.7M300.7M
Current assets1.19B896.8M769.6M713.6M761.3M
Total assets1.55B1.18B1.07B1.17B1.21B
Accounts payable41.0M39.4M28.8M42.0M42.1M
Current liabilities198.1M163.3M142.8M173.6M203.3M
Long-term debt82.4M87.2M93.8M116.4M154.0M
Total liabilities284.4M258.3M243.4M296.7M361.9M
Shareholders' equity1.26B919.0M827.9M877.8M843.9M
Shares outstanding34.1M30.5M30.2M30.5M30.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations158.9M161.0M159.1M60.6M53.0M
Capital spending-13.6M-9.13M-9.80M-36.8M-224.9M
Free cash flow145.3M151.8M149.3M23.9M-172.0M
Dividends paid-121.9M-81.5M-21.1M-15.2M-14.3M
Share buybacks-38.7M-16.3M-14.2M0
Change in cash243.4M41.9M81.4M-67.4M15.8M